Dermata Therapeutics, Inc. (DRMA) DCF Valuation

Dermata Therapeutics, Inc. (DRMA) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Dermata Therapeutics, Inc. (DRMA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore Dermata Therapeutics, Inc. (DRMA) financial future with our user-friendly DCF Calculator! Enter your assumptions for growth, margins, and costs to calculate Dermata Therapeutics, Inc. (DRMA) intrinsic value and refine your investment approach.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -4.5 -3.2 -7.9 .0 .2 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .0 9.7 8.0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -4.5 -3.2 -7.9 -9.7 -7.8 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 2.0 .5 10.8 6.2 7.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .3 .1 .5 .5 .9 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -4.7 -3.4 -7.9 -9.7 -7.8 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -4.4 -3.6 -7.5 .0 .6 -.9 .0 .0 .0 .0
WACC, % 8.19 8.19 8.19 8.19 8.19 8.19 8.19 8.19 8.19 8.19
PV UFCF
SUM PV UFCF -.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -7
Equity Value 7
Diluted Shares Outstanding, MM 0
Equity Value Per Share 34.09

What You Will Get

  • Real Dermata Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Dermata Therapeutics, Inc. (DRMA).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates to fit your analysis needs.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Dermata's fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections specific to Dermata Therapeutics, Inc. (DRMA).
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for your financial assessments.

Key Features

  • Comprehensive DCF Calculator: Features extensive unlevered and levered DCF valuation frameworks.
  • WACC Calculator: Includes a pre-configured Weighted Average Cost of Capital sheet with adjustable inputs.
  • Customizable Forecast Assumptions: Tailor growth rates, capital expenditures, and discount rates to your needs.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Dermata Therapeutics, Inc. (DRMA).
  • Interactive Dashboard and Charts: Visual representations highlight essential valuation metrics for straightforward analysis.

How It Works

  1. Step 1: Download the Excel file for Dermata Therapeutics, Inc. (DRMA).
  2. Step 2: Review Dermata's pre-filled financial data and projections.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model refresh in real-time as you modify assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for your investment strategies.

Why Choose Dermata Therapeutics, Inc. (DRMA) Calculator?

  • Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses tailored for Dermata Therapeutics.
  • Customizable Inputs: Modify yellow-highlighted fields to explore different financial scenarios.
  • Detailed Insights: Automatically computes Dermata's intrinsic value and Net Present Value for informed decision-making.
  • Preloaded Data: Access to historical and projected data for precise analysis.
  • Professional Quality: Perfect for financial analysts, investors, and healthcare consultants focusing on biotech.

Who Should Use This Product?

  • Individual Investors: Gain insights for informed decisions when trading Dermata Therapeutics (DRMA) stock.
  • Financial Analysts: Enhance valuation methodologies with accessible financial models specific to Dermata Therapeutics.
  • Consultants: Provide clients with accurate and timely valuation insights related to Dermata Therapeutics (DRMA).
  • Business Owners: Learn how biotechnology companies like Dermata Therapeutics are valued to inform your strategic planning.
  • Finance Students: Explore valuation techniques through real-world examples involving Dermata Therapeutics (DRMA).

What the Template Contains

  • Preloaded DRMA Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.